I'm sorry but I disagree.
The problem with DNAprint is their "business model".
It has not been working.
Their business plan has worked flawlessly for several years now.
Once they were able to con the investors into allowing them to triple the Authorized Share count from 500 million to 1.5 billion they switched their business plan accordingly. They turned their attention from extracting money from the consumer market and instead decided to obtain all of their revenue from the investment community.
They cut their staff to the bone. Laid off the entire research group, swapped out their management staff and started printing shares. They have made a fortune since that time. When they ran out of shares to print, they did a 20 to 1 reverse split and started over, printing shares as fast as they could sell them.
The business plan has been quite successful. We are now approaching the next phase. They have just about run out of this iteration of shares and so we are waiting to see what the next step will be.
regards,
frog
News 
Market Data 
Discover 
AI
